Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quality of life in Indian patients with functional dyspepsia: Translation and validation of the Hindi version of Short-Form Nepean Dyspepsia Index. | Indian J Gastroenterol | 2022 | 35188623 | PubTator, text mining | PubMed |
| Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use. | PLoS One | 2022 | 35176098 | PubTator, text mining | PubMed |
| Does coupling to ADP ribosylation factor 6 explain differences between muscarinic and other receptors in interaction with β-adrenoceptor-mediated smooth muscle relaxation? | Naunyn Schmiedebergs Arch Pharmacol | 2022 | 35175382 | PubTator, text mining | PubMed |
| Tolvaptan Improves Contrast-Induced Acute Kidney Injury. | J Renin Angiotensin Aldosterone Syst | 2022 | 35173798 | PubTator, text mining | PubMed |
| Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease. | Clin Exp Nephrol | 2022 | 35165806 | PubTator, text mining | PubMed |
| Suitability of GRK Antibodies for Individual Detection and Quantification of GRK Isoforms in Western Blots. | Int J Mol Sci | 2022 | 35163118 | PubTator, text mining | PubMed |
| Endomembrane-Based Signaling by GPCRs and G-Proteins. | Cells | 2022 | 35159337 | PubTator, text mining | PubMed |
| Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKD. | Kidney Int Rep | 2022 | 35155866 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals Olfactory System Expression Characteristics of Aquatic Snakes. | Front Genet | 2022 | 35154285 | PubTator, text mining | PubMed |
| Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones. | Front Pharmacol | 2022 | 35153784 | PubTator, text mining | PubMed |
| A Novel Form of Familial Vasopressin Deficient Diabetes Insipidus Transmitted in an X-linked Recessive Manner. | J Clin Endocrinol Metab | 2022 | 35137152 | PubTator, text mining | PubMed |
| Approach to the Patient: "Utility of the Copeptin Assay". | J Clin Endocrinol Metab | 2022 | 35137148 | PubTator, text mining | PubMed |
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. | Nephrol Dial Transplant | 2022 | 35134221 | PubTator, text mining | PubMed |
| Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy. | Acta Pharm Sin B | 2022 | 35127374 | PubTator, text mining | PubMed |
| Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor. | J Biol Chem | 2022 | 35101446 | PubTator, text mining | PubMed |
| Pharmacological chaperones for the oxytocin receptor increase oxytocin responsiveness in myometrial cells. | J Biol Chem | 2022 | 35093385 | PubTator, text mining | PubMed |
| GPCR kinase knockout cells reveal the impact of individual GRKs on arrestin binding and GPCR regulation. | Nat Commun | 2022 | 35087057 | PubTator, text mining | PubMed |
| Nonsense Suppression Therapy: An Emerging Treatment for Hereditary Skin Diseases. | Acta Derm Venereol | 2022 | 35083492 | PubTator, text mining | PubMed |
| Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer bias. | Nat Commun | 2022 | 35078997 | PubTator, text mining | PubMed |
| Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial. | PLoS One | 2022 | 35077456 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=31